Joshua Brody  

Innovative research pioneer Joshua Brody, the Director of the Lymphoma Immunotherapy Program at the Mount Sinai Icahn School of Medicine, sits down with Aaron to talk about new advances in cancer research.  He shares his expertise in the study of leukemia and the exciting breakthroughs in healing patients who suffer from the disease.  They also discuss the causes of cancer and kind of misinformation that gets shared about environmental conditions and other factors which may cause or contribute to the start of various cancers.   Brody gives his insights on the future of cancer treatment and what can be expected in the coming decade.

 

In this special series on the work of some of our nation’s best doctors to cure and fight dangerous diseases, Aaron is joined in the program’s first segment by Anthony Fauci, the Director of the Institute of Allergy and Infectious Diseases at the National Institutes of Health to continue their ongoing discussion of the battle to control and even eradicate some of the planet’s deadliest and most insidious diseases. In the program’s second segment. Aaron’s guest is Dr. Joshua Brody, the Director of the Lymphoma Immunotherapy Program at the Mount Sinai Icahn School of Medicine in New York City. The focus of the discussion with Dr. Brody is how quickly immunotherapy is evolving and what the expanding options for cancer patients are.

 
Join the conversation on the #AHShow!
The Aaron Harber Show

@AaronHarber

     

 

Having trouble viewing this video? Click here to us know.